[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100574264":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":11,"locations":17,"responsibleParty":42,"collaborators":10,"id":47,"slug":10,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":10,"eligibilityCriteria":51,"healthyVolunteers":48,"sex":52,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":10,"studyType":58,"phases":10,"briefSummary":59,"conditions":60,"keywords":10,"overallStatus":20,"whyStopped":10,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"The First Affiliated Hospital of Xiamen University","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"Patients undergoing breast cancer surgery with general anesthesia in the hospital",null,[12],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":16},"Bin Yang doctor","CONTACT","1385998603","yangbin4332@outlook.com",[18,34],{"facility":19,"status":20,"city":21,"state":22,"zip":23,"country":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"First Affiliated Hospital of Xiamen University","RECRUITING","Xiamen","Fujian","361000","China",{"type":26,"coordinates":27},"Point",[28,29],118.08187,24.47979,{"lat":29,"lon":28},[32],{"name":13,"role":14,"phone":33,"phoneExt":10,"email":16},"86+1385998603",{"facility":19,"status":20,"city":21,"state":22,"zip":23,"country":24,"cosmosGeoPoint":35,"geoPoint":37,"contacts":38},{"type":26,"coordinates":36},[28,29],{"lat":29,"lon":28},[39],{"name":13,"role":14,"phone":40,"phoneExt":10,"email":41},"+86 13950374558","2389899106@qq.com",{"type":43,"investigatorFullName":44,"investigatorTitle":45,"investigatorAffiliation":46,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Yang Bin","Principal Investigator","Fujian Medical University","100574264",false,"NCT06757023","A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment","Inclusion Criteria:\n\n1. Patients undergoing breast cancer surgery with general anesthesia in the hospital;\n2. American Society of Anesthesiologists (ASA) classification I-II;\n3. Women aged 18-55 years;\n4. No history of chronic insomnia;\n5. Individuals who have not taken sedative-hypnotic drugs within the past month.\n\nExclusion Criteria:\n\n1. Those who do not meet the aforementioned inclusion criteria;\n2. A history of severe heart, brain, lung, or kidney diseases (such as acute coronary syndrome (ACS), severe heart failure classified as NYHA Class III or IV, severe arrhythmias, severe valvular disease; acute aortic disease, and severe peripheral vascular disease, etc.), or poor physical condition (including reduced exercise tolerance, multi-organ dysfunction, malnutrition, etc.);\n3. A history of sleep disorders and psychiatric history;\n4. Inability to receive thumb-tack needle treatment.","ALL","18 Years","55 Years",{"count":56,"type":57},110,"ESTIMATED","OBSERVATIONAL","To understand the impact of thumb-tack needle therapy on postoperative sleep and recovery in patients who have undergone general anesthesia, and to explore the clinical significance of thumb-tack needle therapy in improving postoperative sleep quality, preventing postoperative sleep disorders, and promoting postoperative recovery",[61,62,63],"Postoperative Complications","Postoperative Pain","Acupuncture","2024-12-25",{"date":66,"type":67},"2025-01-03","ACTUAL",{"date":69,"type":67},"2024-11-13",{"date":71,"type":57},"2026-11-13",{"name":5,"class":6},2]